OpGen(OPGN)

0.4030 -0.1320 -24.6729%

今开:0.5昨收:0.535
最高:0.5 最低:0.4026
涨停价:0.0跌停价:0.0
总市值:5087836.0

OpGen的热门讨论

贵族的财富大师03-26 23:22

$ABVC BioPharma(ABVC)$ $OpGen(OPGN)$ OPGN 在0.24CD指标提示抄底之后,蜡烛图不破蓝色梯子下边缘不卖出
图中的抄底是CD指标自带的查看全文

首次持股声明

OpGen(OPGN)04-03 21:25

$OpGen(OPGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000921895-24-000775  Size: 3 KB 网页链接查看全文

股东委托书协议

OpGen(OPGN)04-26 19:35

$OpGen(OPGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001829126-24-002814  Act: 34  Size: 457 KB 网页链接查看全文

当期报告

OpGen(OPGN)02-08 20:35

$OpGen(OPGN)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001079973-24-000177  Act: 34  Size: 213 KB 网页链接查看全文

首次持股声明

OpGen(OPGN)04-03 21:15

$OpGen(OPGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000921895-24-000772  Size: 3 KB 网页链接查看全文

持股变动声明

OpGen(OPGN)04-13 05:15

$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-000831  Size: 4 KB 网页链接查看全文

持股变动声明

OpGen(OPGN)04-13 05:05

$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-000829  Size: 4 KB 网页链接查看全文

当期报告

OpGen(OPGN)04-17 18:05

$OpGen(OPGN)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001829126-24-002584  Act: 34  Size: 283 KB 网页链接查看全文

其他

OpGen(OPGN)04-04 05:35

$OpGen(OPGN)$ SC 14F1 Statement regarding change in majority of directors [Rule 14f-1] Accession Number: 0001829126-24-002194  Act: 34  Size: 256 KB 网页链接查看全文

首次持股声明

OpGen(OPGN)04-03 21:25

$OpGen(OPGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000921895-24-000774  Size: 3 KB 网页链接查看全文

1 2 3

OpGen的最新讨论

贵族的财富大师03-26 23:22

$ABVC BioPharma(ABVC)$ $OpGen(OPGN)$ OPGN 在0.24CD指标提示抄底之后,蜡烛图不破蓝色梯子下边缘不卖出
图中的抄底是CD指标自带的查看全文

小鱼201503072023-10-12 22:18

$OpGen(OPGN)$ 病毒检测股查看全文

韩信超短2023-10-12 22:16

$OpGen(OPGN)$ 转到你这边来了查看全文

Bio News |诺华与Ares Genetics合作研发新型抗生素

牛股小红书2022-04-07 14:13

诺华的Sandoz将其与$OpGen(OPGN)$ 的子公司Ares Genetics的战略合作延长至2025年1月31日,旨在推动对抗耐药性的尖端数字解决方案。
两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文

TOPVIEW | 2021.10.6 Bio-market主要涨跌一览

蹊之美股生物医药2021-10-08 00:15

作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers: 
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文

7X24快讯2021-06-15 16:37

分子诊断公司OpGen(OPGN.O)盘前涨38%,此前公司CEO与COO买入公司股份。查看全文

东哥_Singapore2021-03-08 23:42

$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文

1 2 3 4 5 6 7 8 9 10 11 12

OpGen的公告

$OpGen(OPGN)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-02-28 AccNo: 0001104659-19-011585 Size: 371 KB 网页链接

$OpGen(OPGN)$ 8-K - Current report Filed: 2019-02-26 AccNo: 0001079973-19-000099 Size: 187 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$OpGen(OPGN)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-02-27 AccNo: 0001564590-19-004950 Size: 9 MB 网页链接

$OpGen(OPGN)$ 8-K - Current report Filed: 2019-02-25 AccNo: 0001079973-19-000096 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial Stateme...

$OpGen(OPGN)$ 美东时间 2019-02-26 盘后 披露财报,预期EPS -0.38 网页链接

$OpGen(OPGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0000919574-19-001717 Size: 110 KB 网页链接

$OpGen(OPGN)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-02-14 AccNo: 0001193125-19-039762 Size: 106 KB 网页链接

$OpGen(OPGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-15 AccNo: 0000902664-19-000190 Size: 63 KB 网页链接

$OpGen(OPGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-03 AccNo: 0001535610-19-000014 Size: 15 KB 网页链接

$OpGen, Inc.(OPGN)$ 8-K - Current report Filed: 2018-11-21 AccNo: 0001079973-18-000649 Size: 15 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58